John R Lake

Active

CB8025-21845: A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple CenterStudy To Evaluate The Safety, Tolerability, And Efficacy Of Seladelpar AdministeredFor 24 Weeks In Adult Subjects With Primary Sclerosing Cholangitis

Lake, J. R.

CYMABAY THERAPEUTICS, INC

1/29/20 → 7/30/20

Project: Research project

2017-AAR-010: ALFAPUMP SYSTEM IN THE TREATMENT OF REFRACTORY OR RECURRENT ASCITES: A MULTICENTER SINGLE ARM WITHIN SUBJECT CROSSOVER DESIGN PIVOTAL STUDY (THE POSEIDON STUDY)

Lake, J. R.

SEQUANA MEDICAL

9/11/19 → 9/30/24

Project: Research project

Hepatic Energy Fluxes, NASH, and Vertical Sleeve Gastrectomy

Ikramuddin, S., Amin, K., Bolan, P. J., Chauhan, A., Connett, J. E., Crawford, P., Lake, J. R. & d'Avignon, D.

NIH Natl Inst of Diabetes/Dig/Kidney Dis

8/1/19 → 5/31/21

Project: Research project

A 52-week, placebo-controlled, randomized, Phase 3 study to evaluate the safety and efficacy of seladelpar in subjects with primary biliary cholangitis (PBC) and an inadequate response to or an intolerance to ursodeoxycholic acid (UDCA)

Lake, J. R.

CYMABAY THERAPEUTICS, INC

9/1/18 → 8/30/22

Project: Research project

Scientific Registry of Transplant Recipients (SRTR)

Lake, J. R.

HENNEPIN HEALTHCARE RESEARCH INSTITUTE

9/21/15 → 9/20/20

Project: Research project

A Randomized, Open-Label, Multicenter, Controlled Study

Thompson, J. A. & Lake, J. R.

VITAL THERAPIES, INC.

5/17/12 → 6/30/20

Project: Research project

Finished

Open-label Study to Evaluate the Safety and Efficacy

Lake, J. R.

ABBVIE INC.

7/1/15 → 10/31/16

Project: Research project

Multicenter, Prospective Evaluation of the Cepheid Xpert

Lake, J. R.

Beckman Coulter, Inc.

3/3/14 → 4/30/18

Project: Research project

MASTER CLINICAL TRIAL AGREEMENT

Lake, J. R.

SC LIVER RESEARCH CONSORTIUM, LLC.

2/5/14 → 2/4/19

Project: Research project

A Randomized, Global, Double-blind, Placebo-controlled,

Lake, J. R.

EISAI MEDICAL RESEARCH INC.

10/21/13 → 6/30/17

Project: Research project

A Multi-Center, Double-Blind, Randomized, Controlled

Lake, J. R.

CUMBERLAND PHARMACEUTICALS, INC.

10/7/13 → 6/30/16

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ran

Lake, J. R.

SALIX PHARMACEUTICALS, INC.

9/26/13 → 12/27/16

Project: Research project

Multicenter, Randomized Phase 2B Study to Evaluate the E

Lake, J. R.

OCERA THERAPEUTICS, INC.

8/12/13 → 3/31/17

Project: Research project

A Phase 2, Multicenter, Open-Label Study to Investigate

Lake, J. R.

Gilead Sciences, Inc.

7/12/13 → 12/31/15

Project: Research project

Scientific Registry of Transplant Recipients (SRTR)

Lake, J. R.

HENNEPIN HEALTHCARE RESEARCH INSTITUTE

6/1/13 → 9/20/15

Project: Research project

A Phase 2, Randomized, Multicenter, Placebo-Controlled,

Lake, J. R.

EISAI MEDICAL RESEARCH INC.

12/22/11 → 8/3/12

Project: Research project

A Multi-Center, Randomized, Placebo-Controlled, Double-B

Lake, J. R.

IKARIA THERAPEUTICS, LLC

8/3/10 → 12/31/13

Project: Research project

A 24-month randomized, multicenter study, evaluating eff

Lake, J. R.

NOVARTIS PHARMACEUTICALS CORPORATION

3/22/10 → 9/30/13

Project: Research project

A 24 Month, multi-center, open-lable randomized, control

Lake, J. R.

Novartis Pharma AG

7/2/09 → 1/4/12

Project: Research project

A Phase 2, Randmized, Multicenter, Placebo-Controlled, D

Lake, J. R.

EISAI MEDICAL RESEARCH INC.

4/6/09 → 12/31/13

Project: Research project

Optimal Long-Term Outcome of Chronic Hepatitis B

Smith, C., Hassan, M. A. & Lake, J. R.

Mayo Clinic Rochester

9/30/08 → 5/31/15

Project: Research project

A Phase 2, Open-Label, Multi-Center, Randomized Trial to

Lake, J. R.

LIFECYCLE PHARMA

9/10/08 → 2/10/12

Project: Research project

A Phase 2, Randomized, Double-Blind, Placebo-Controlled

Lake, J. R.

Hyperion Therapeutics

2/1/08 → 2/4/09

Project: Research project

A phase II, open-label, multi-center,prospective, random

Lake, J. R.

LIFECYCLE PHARMA

1/3/08 → 12/31/10

Project: Research project

A Phase II, Open-Label, Multi-Center Prospective, Conver

Lake, J. R. & Humar, A.

CTI CLINICAL TRIAL SERVICES, INC.

10/22/07 → 12/31/08

Project: Research project

A Open-Label Phase II Extension Study for Patients Compl

Lake, J. R. & Humar, A.

CTI CLINICAL TRIAL SERVICES, INC.

10/22/07 → 6/30/10

Project: Research project

Evaluation of Belatacept as First-Line Immunosuppression

Lake, J. R.

BRISTOL-MYERS SQUIBB COMPANY

8/10/07 → 12/31/15

Project: Research project

A Phase 2, Double-Blind, Multi-Center, Randomized Study

Lake, J. R.

Gilead Sciences, Inc.

12/31/05 → 12/12/12

Project: Research project

REFINE: Randomized, evaluation of fibrosis due to hepati

Lake, J. R.

NOVARTIS PHARMACEUTICALS CORPORATION

9/14/05 → 9/30/10

Project: Research project

A Prospective, Randomized, Multicenter, Open-Label, Comp

Lake, J. R.

ROCHE LAB INC

1/10/05 → 3/31/10

Project: Research project